Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01085045 · COMPLETED
Trial details
- NCT number
- NCT01085045
- Sponsor
- Pearl Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-11-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.